Long-term results after partial left ventriculectomy

Matthias Claus1, Mark Beling, Andrea Grohmann

  • 1Klinik für Innere Medizin mit Schwerpunkt Kardiologie, Angiologie und Pulmologie, Universitätsklinikum Charité, Campus Mitte, Humboldt-Universität, Schumannstr. 20/21, D-10117, Berlin, Germany. matthias.claus@charite.de <matthias.claus@charite.de>

Insights

Partial left ventriculectomy (PLV) shows high mortality and no long-term cardiac performance improvement in heart failure patients. Key predictors of mortality include reduced ventricular wall thickness and poor response to dobutamine.

Area of Science:

  • Cardiovascular Surgery
  • Heart Failure Management
  • Surgical Outcomes Research

Background:

  • Partial left ventriculectomy (PLV) is a surgical option for advanced heart failure.
  • Long-term effects and outcome predictors following PLV require thorough investigation.

Purpose of the Study:

  • To determine the long-term clinical, echocardiographic, and hemodynamic effects of PLV.
  • To identify predictors of outcome after PLV in patients with various cardiomyopathies.

Main Methods:

  • PLV was performed on 39 patients (NYHA class III/IV) with dilated, ischemic, or valvular cardiomyopathy.
  • Follow-up included clinical, echocardiographic, hemodynamic assessments, and stress testing up to 24 months.
  • Concomitant procedures like CABG and valve surgery were performed as needed.

Main Results:

  • Actuarial survival rates were 64% at 1 year, 55% at 2 years, and 44% at 3 years.
  • Significant improvement in NYHA functional class was observed at 2-year follow-up.
  • No significant long-term improvement in LV ejection fraction, LV end-diastolic diameter, cardiac index, or peak oxygen consumption was noted.

Conclusions:

  • PLV is associated with significant postoperative mortality.
  • The procedure does not provide sustained long-term improvement in cardiac performance.
  • Decreased left ventricular wall thickness and inadequate stroke volume index response to dobutamine predict mortality.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...